Epidemiology and renal injury following 2-methyl-4-chlorophenoxyacetic acid (MCPA) poisoning.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 12 2022
Historique:
received: 17 01 2022
accepted: 28 11 2022
entrez: 19 12 2022
pubmed: 20 12 2022
medline: 22 12 2022
Statut: epublish

Résumé

2-Methyl-4-chlorophenoxyacetic acid (MCPA) is a widely used chlorophenoxy herbicide. MCPA poisoning causes mitochondrial dysfunction, which can lead to kidney injury and death. The objective of this study is to describe the epidemiology, case fatality and extent of renal injury in a large cohort of MCPA self-poisonings. The study consists of two parts: (1) A report of epidemiological data and clinical outcomes in MCPA poisoned patients in Sri Lanka between 2002 and 2019; (2) Evaluation of acute kidney injury (AKI) using renal biomarkers in a subset from this cohort. Serum creatinine (sCr) and biomarkers were measured soon after hospitalization (2 [IQR 1-3] h) and at different time intervals. We measured serum biomarkers: sCr, cystatin C (sCysC), creatine kinase (CK), and urinary biomarkers: creatinine, kidney injury molecule-1 (KIM-1), clusterin, albumin, beta-2-microglobulin (β2M), cystatin C, neutrophil gelatinase-associated lipocalin (NGAL), osteopontin (OPN), trefoil factor 3 (TFF3) and cytochrome C (CytoC). Kidney Disease Improving Global Outcomes (KDIGO) criteria was used to define acute kidney injury (AKI). There were 1653 patients; 65% were male. The median time from ingestion to examination was 3:54 (IQR 2:19-6:57) h. The overall case-fatality rate was 5.3%. Patients who died were older (42 [IQR 33.5-54] vs 27 [IQR 20-37] for survivors). The median estimated amount of MCPA ingested by patients who died was also greater (88 [IQR 34-200] vs. 30 [IQR 15-63] ml in survivors). Moderate to severe AKI (AKI2/3) was uncommon (6/59 patients in the biomarker study had KDIGO stage 2 or 3). Most patients in AKI2/3 group with increased sCr were older (median age 35 years [IQR 27-41]) compared to No AKI (23 years (19-29) years) or AKI1 (26 years (21-40) years) group who had no or mild increase in sCr. These patients had no pre-existing kidney diseases. In these patients, serum creatinine (maximum medium concentration; 1.12 [IQR 0.93-1.67] mg/dl) and CK (maximum medium concentration; 284 [IQR 94-428] U/l) were increased but sCysC (maximum medium concentration; 0.79 [IQR 0.68-0.81] mg/l) remained in the normal range within 72 h. All urinary biomarkers performed poorly in diagnosing AKI (area under the receiver operating characteristic curve < 0.68). The higher numbers of men with MCPA poisoning likely reflects greater occupational access to pesticides. Fatal outcome and higher ingested dose were more common in the elderly. Significant AKI with tubular injury biomarkers was uncommon. Most people with raised sCr were older and appeared to have no pre-existing kidney disease.

Identifiants

pubmed: 36535986
doi: 10.1038/s41598-022-25313-z
pii: 10.1038/s41598-022-25313-z
pmc: PMC9763389
doi:

Substances chimiques

2-Methyl-4-chlorophenoxyacetic Acid D888C394VO
Biomarkers 0
Creatinine AYI8EX34EU
Cystatin C 0
Lipocalin-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21940

Informations de copyright

© 2022. The Author(s).

Références

Environ Toxicol Pharmacol. 2020 Nov;80:103510
pubmed: 33031936
J Res Med Sci. 2018 Sep 24;23:82
pubmed: 30294350
Clin Toxicol (Phila). 2019 Nov;57(11):1080-1086
pubmed: 30888889
Clin Toxicol (Phila). 2017 Nov;55(9):970-976
pubmed: 28535124
Ann Emerg Med. 2005 Sep;46(3):275-84
pubmed: 16126140
Clin Toxicol (Phila). 2018 Sep;56(9):861-863
pubmed: 29382245
Clin Toxicol (Phila). 2009 Sep;47(8):836-7
pubmed: 19725771
Stroke. 2011 Jul;42(7):1826-33
pubmed: 21546482
Toxicol Lett. 2015 Sep 2;237(2):140-50
pubmed: 26071311
Toxicol Lett. 2011 Mar 25;201(3):270-6
pubmed: 21256202
J Toxicol Clin Toxicol. 2000;38(2):111-22
pubmed: 10778907
J Res Pharm Pract. 2018 Oct-Dec;7(4):178-181
pubmed: 30622984
Lancet Glob Health. 2021 Jun;9(6):e854-e862
pubmed: 33901424
Toxicol Lett. 2018 Dec 15;299:182-190
pubmed: 30300734
Indian J Nephrol. 2013 May;23(3):180-3
pubmed: 23814415
Sci Rep. 2017 Jan 23;7:41012
pubmed: 28112204
Biochem Res Int. 2012;2012:951539
pubmed: 22482055
Annu Rev Pharmacol Toxicol. 2008;48:463-93
pubmed: 17937594
Br J Psychiatry. 2005 Dec;187:583-4
pubmed: 16319413
Nat Biotechnol. 2010 May;28(5):470-7
pubmed: 20458317
Front Med (Lausanne). 2017 Jun 15;4:73
pubmed: 28664159
Crit Care. 2007;11(2):R31
pubmed: 17331245

Auteurs

Thilini M Wijerathna (TM)

South Asian Clinical Toxicology Research Collaboration, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka. wijerathnapa@kdu.ac.lk.
Department of Biosystems Technology, Faculty of Technology, General Sir John Kotelawala Defence University, Ratmalana, Sri Lanka. wijerathnapa@kdu.ac.lk.

Nicholas A Buckley (NA)

South Asian Clinical Toxicology Research Collaboration, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.
Clinical Pharmacology and Toxicology Research Group, Faculty of Medicine and Health, Biomedical Informatics and Digital Health, The University of Sydney, Sydney, NSW, 2006, Australia.

Indika B Gawarammana (IB)

South Asian Clinical Toxicology Research Collaboration, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.
Department of Medicine, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.

Jacques Raubenheimer (J)

Clinical Pharmacology and Toxicology Research Group, Faculty of Medicine and Health, Biomedical Informatics and Digital Health, The University of Sydney, Sydney, NSW, 2006, Australia.

Seyed Shahmy (S)

South Asian Clinical Toxicology Research Collaboration, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.
National Science and Technology Commission of Sri Lanka, Colombo, Sri Lanka.

Umesh Chathuranga (U)

South Asian Clinical Toxicology Research Collaboration, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.

Chathura Palangasinghe (C)

South Asian Clinical Toxicology Research Collaboration, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.

Fathima Shihana (F)

South Asian Clinical Toxicology Research Collaboration, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.
Clinical Pharmacology and Toxicology Research Group, Faculty of Medicine and Health, Biomedical Informatics and Digital Health, The University of Sydney, Sydney, NSW, 2006, Australia.
Centenary Institute of Cancer Medicine & Cell Biology, The University of Sydney, Camperdown, NSW, Australia.

Fahim Mohamed (F)

South Asian Clinical Toxicology Research Collaboration, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.
Department of Pharmacy, Faculty of Allied Health Science, University of Peradeniya, Peradeniya, Sri Lanka.
The Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, & The University of Sydney, Faculty of Medicine and Health, Department of Pharmacology, Sydney Pharmacy School, The University of Sydney, Sydney, Australia.
Australian Kidney Biomarker Reference Laboratory, Department of Nephrology, Prince of Wales Hospital and Clinical School, University of New South Wales, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH